Table 1 Demographic data, CD4+ T cell count, viral load and HAART treatment of studied subjects.
From: Clinical analysis of HIV/AIDS patients with drug eruption in Yunnan, China
Drug eruption group n = 134 (%) | Control group n = 268 (%) | P value | ||
---|---|---|---|---|
Age | Mean ± SD | 41.43 ± 12.39 | 43.31 ± 12.96 | 0.164 |
≤30 | 27 (20.1) | 38 (14.2) | 0.460 | |
31–40 | 49 (36.6) | 89 (33.2) | ||
41–50 | 29 (21.6) | 85 (31.7) | ||
51–60 | 17 (12.7) | 24 (9.0) | ||
>60 | 12 (9.0) | 32 (11.9) | ||
Sex | Male | 89 (66.4) | 199 (74.2) | 0.100 |
Female | 45 (33.6) | 69 (25.8) | ||
CD4+ T cell count | Median ± IRb | 151.00 ± 221.50 | 135.00 ± 246.75 | 0.267 |
HIV-1 viral load | Median ± IR | 3220.00 ± 361450.00 | 27650.00 ± 461950.00 | 0.436 |
HAART | Yes | 82 (61.2) | 192 (71.6) | 0.034a |
No | 52 (38.8) | 76 (28.4) | ||
Allergic history | Yes | 21 (15.7) | 20 (7.5) | 0.010a |
No | 113 (84.3) | 248 (92.5) |